Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers

1. Inclusion Criteria * Healthy adult volunteers aged 19 years or older at screening. * Body weight ≥ 50.0 kg and body mass index (BMI) between 18.0 kg/m² and 30.0 kg/m² at screening. \* BMI (kg/m²) = weight (kg) / {height (m)}² * No congenital or chronic medical conditions requiring treatment, and no pathological signs or findings upon medical examination. * Clinical laboratory tests, vital signs, physical examination, and 12-lead electrocardiogram (ECG) results at screening indicate suitability for participation based on the characteristics of the investigational medicinal product. * Fully understood the detailed explanation of this clinical trial, voluntarily agreed to participate, and provided written informed consent agreeing to comply with study requirements during the trial period. 2. Exclusion Criteria * History or current clinically significant liver, kidney, neurological, psychiatric, respiratory, endocrine, hematological, neoplastic, genitourinary, cardiovascular, gastrointestinal, or musculoskeletal disorders. * Female subjects who are pregnant (urine hCG positive) or breastfeeding. * History of hypersensitivity (e.g., anaphylaxis, angioedema) or clinically significant allergic reactions to the active ingredient, excipients of the investigational product, or other medications (e.g., aspirin, penicillin antibiotics, macrolide antibiotics). * History of gastrointestinal diseases or surgeries that could affect absorption of the inve…